2010
DOI: 10.1186/1757-1626-3-53
|View full text |Cite
|
Sign up to set email alerts
|

Four different malignancies in one patient: a case report

Abstract: Cancer survivors have a higher risk of new primary cancer, in the same or in another organ, than the general population. We report a 78-year-old women who has metachronous quadruple adenocarcinoma, includes bilateral breast cancer, ovarian cancer and retroperitoneal neuroendocrine carcinoma. The development of second cancer in cancer survivors can be expected but third or higher order malignancies are rare.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Eight cases experienced dead/metastasis or recurrence. [ 3 , 4 , 13 , 16 , 17 , 19 , 20 , 24 ] The outcomes of cases were not reported. [ 6 9 , 23 ]…”
Section: Discussionmentioning
confidence: 99%
“…Eight cases experienced dead/metastasis or recurrence. [ 3 , 4 , 13 , 16 , 17 , 19 , 20 , 24 ] The outcomes of cases were not reported. [ 6 9 , 23 ]…”
Section: Discussionmentioning
confidence: 99%
“…Multiple Primary Malignancies (MPMs) include the presence of two or more distinctive primary malignancies, apart from metastases, in a single patient (1,2). Because of the increasing number of cancer survivors, improved screening and diagnostic systems, and increased number of the older population, MPMs also have been on the rise (2,3).…”
Section: Introductionmentioning
confidence: 99%
“…Multiple Primary Malignancies (MPMs) include the presence of two or more distinctive primary malignancies, apart from metastases, in a single patient (1,2). Because of the increasing number of cancer survivors, improved screening and diagnostic systems, and increased number of the older population, MPMs also have been on the rise (2,3). According to the Surveillance, Epidemiology, and End Results Program (SEER) database, malignancies that are seen at the same time or with an interval of two months are synchronous and those seen at an interval of more than two months are metachronous.…”
Section: Introductionmentioning
confidence: 99%